Vancouver, Canada

Mehran Seid Bagherzadeh

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 12.4

ph-index = 5

Forward Citations = 92(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Inventor Spotlight: Mehran Seid Bagherzadeh

Introduction:

Mehran Seid Bagherzadeh, a prolific inventor based in North Vancouver, CA, has made significant contributions to the field of pharmaceuticals with his inventive spirit and dedication to innovation.

Latest Patents:

Among his impressive portfolio of 8 patents, Mehran's latest inventions include groundbreaking methods for utilizing spiro-oxindole compounds as therapeutic agents, targeting hypercholesterolemia, benign prostatic hyperplasia, pruritis, and cancer. Additionally, his work on pyridyl derivatives as therapeutic agents showcases his commitment to advancing treatments for SCD-mediated diseases.

Career Highlights:

Mehran Seid Bagherzadeh is currently associated with Xenon Pharmaceuticals Inc., a renowned player in the pharmaceutical industry known for its cutting-edge research and development initiatives. His role within the company underscores his expertise and influence in driving forward the frontiers of medical science.

Collaborations:

In his professional journey, Mehran has collaborated closely with esteemed colleagues such as Rajender Kamboj and Serguei Sviridov. Together, they have pioneered new approaches to tackling complex medical challenges, setting new standards for innovation and excellence in the field.

Conclusion:

In conclusion, Mehran Seid Bagherzadeh stands out as a visionary inventor who continues to push boundaries and redefine possibilities in the realm of pharmaceutical research. His dedication to developing novel therapeutic solutions underscores his commitment to improving global healthcare outcomes and leaves a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…